Pages that link to "Q34703660"

The following pages link to PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma (Q34703660):

Displaying 12 items.

• A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors (Q33437948) (← links)
• Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents (Q35214924) (← links)
• Opportunities and challenges of radiotherapy for treating cancer (Q38539957) (← links)
• Gene regulation and genetics in neurochemistry, past to future. (Q38802501) (← links)
• Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies (Q38828275) (← links)
• Notch signaling in cerebrovascular diseases (Review) (Q38940654) (← links)
• Induction of reactive oxygen species: an emerging approach for cancer therapy (Q46302962) (← links)
• Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p. (Q46341905) (← links)
• Epigenetic regulation of neuroblastoma development (Q48209723) (← links)
• Targeting of epigenetic regulators in neuroblastoma. (Q52560224) (← links)
• HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II. (Q52728397) (← links)
• Histone Deacetylase Inhibitors: A Prospect in Drug Discovery (Q95853354) (← links)